| |
Journal of Neurochemistry, Vol. 103, No. 6. (2007), pp. 2268-2280.
|
| |
Mol Pharmacol, Vol. 66, No. 3. (1 September 2004), pp. 468-477.
|
| |
Molecular and Cellular Neuroscience, Vol. 28, No. 2. (February 2005), pp. 375-389.
|
| |
Neuropharmacology, Vol. In Press, Corrected Proof
|
| |
J Physiol, Vol. 536, No. Pt 1. (1 October 2001), pp. 35-47.
|
| |
Naunyn Schmiedebergs Arch Pharmacol, Vol. 348, No. 6. (December 1993), pp. 566-575.
|
| |
J Neurosci, Vol. 19, No. 3. (1 February 1999), pp. 890-899.
|
| |
Br J Pharmacol, Vol. 140, No. 3. (2003), pp. 558-566.
|
| |
Nature Reviews Neuroscience, Vol. 8, No. 6. (June 2007), pp. 451-465.
|
| |
Mol Pharmacol, Vol. 70, No. 2. (1 August 2006), pp. 676-685.
|
| |
Neuropharmacology, Vol. 50, No. 8. (June 2006), pp. 984-990.
|
| |
Endocrinology, Vol. 141, No. 8. (August 2000), pp. 2930-2937.
|
| |
PNAS, Vol. 80, No. 7. (1 April 1983), pp. 2086-2090.
|
| |
J. Neurosci., Vol. 19, No. 10. (15 May 1999), pp. 3773-3780.
|
| |
J. Biol. Chem., Vol. 278, No. 21. (23 May 2003), pp. 18776-18784.
|
| |
Br J Pharmacol, Vol. 148, No. 7. (19 June 2006), pp. 947-955.
|
| |
Br J Pharmacol, Vol. 143, No. 6. (25 October 2004), pp. 685-696.
|